Implantable Medical Devices Market Size, Share, and Trends 2024 to 2034

The global implantable medical devices market size was valued at USD 105.7 billion in 2023 and is expected to hit USD 207 billion by 2033, poised to grow at a CAGR of 6.9% from 2024 to 2033.

Key Takeaway:

• North America contributed more than 40.91% of revenue share in 2023.
• By product type, the orthopedic implants segment has contributed 45.12% market share in 2023.
• By Biomaterial, the metallic segment is estimated to hold the highest market share of 49.73% in 2023.
• By End User, the hospital segment accounted for 55.22% market share in 2023.

Implantable Medical Devices Market in the U.S. 2024 to 2033

The U.S. implantable medical devices market size was valued at USD 35.29 billion in 2023 and is expected to reach around USD 65.12 billion by 2033, growing at a CAGR of 6.3% from 2024 to 2033.

Based on region, North America dominated the global implantable medical devices market in 2023, in terms of revenue and is estimated to sustain its dominance during the forecast period. North America is characterized by the increased prevalence of various chronic diseases and increasing geriatric population. Further, the increased disposable income, presence of advanced healthcare infrastructure, increasing adoption of minimally invasive surgeries, and rising consumer expenditure on healthcare are the major factors that are expected to drive the growth of the medical implants market in the region. Further, the number of medical visits in the US is rising. According to the CDC, approximately 64% of the US population of age between 18 years to 64 years, visited clinics related to their medical health in 2017. Moreover, the increased awareness among the population in North America regarding the availability of various medical implants has significantly contributed towards the market growth in the past.

On the other, Asia Pacific is estimated to be the most opportunistic market during the forecast period. This is attributed to the rising geriatric population. According to the United Nations, around 80% of the global geriatric population is expected to be living in the low and middle income nations. Further, the rising government and corporate investments in the development of advanced healthcare infrastructure in the region is anticipated to boost the market growth in the region.

Growth Factors

The technological advancements in the healthcare industry has allowed the people to improve their looks and enhance their beauty by implanting medical devices such as dental implants, breast implants, pectoral implants, deltoid implants, and cochlear implants. The rising concerns regarding the aesthetics and physical appearances among the population is another factor that drives the demand for the implantable medical devices. Moreover, the presence of numerous market players and various developmental strategies adopted by them plays a prominent role in influencing the market. Furthermore, the rising number of accident cases in which limbs or organs are damaged is a major factors that may drive the demand for the implantable medical devices across the globe. All these factors are expected to drive the growth of the global implantable medical devices market during the forecast period.

The increasing awareness regarding the availability of implantable medical devices, presence of advanced healthcare infrastructure, rising disposable income, and increasing consumer expenditure on healthcare are the prominent drivers that boosts the adoption of the implantable medical devices among the patients. Furthermore, the rising prevalence of chronic diseases ad growing geriatric population across the globe are the primary drivers of the global implantable medical devices market.According to the United Nations, there were around 382 million old age people, aged 60 years or above, across the globe in 2017 and this number is expected 2.1 billion by 2050. The old age people are prone to various chronic diseases such as cardiovascular diseases, endovascular diseases, orthopedic disorders, and dental disorders, which can foster the demand for the implantable medical devices across the globe. The kidney implants, joints implants, eye implants, and heart implants are some of the common implantable medical devices among the geriatric people. Moreover, availability of wider range of different implantable medical devices serves a wider need for the implants such as cardiovascular implants, orthopedic implants, and various other types of implants.

Implantable Medical Devices Market Scope

Product Type Insights

Based on the product, the orthopedic implants segment accounted largest revenue share in 2023. Orthopedic implants are extensively used across the globe for replacing the missing bones or joints and to support the damaged bones. The rising cases of accidents that leads to damage bones and joints is augmenting the growth of this segment. Further the rising cases of rheumatoid arthritis is giving rise to the elbow joint replacement surgeries. According to the Australia Bureau of Statistics, around 458,000 people have rheumatoid arthritis. In 2017-18. Moreover, according to the Arthritis Report UK, around 17.8 million people were living with a musculoskeletal condition in 2018. Hence, this is resulting in the increased number of orthopedic surgeries that may boost the growth of the orthopedic implants in the upcoming years.

On the other hand, the dental segment is estimated to be the most opportunistic segment during the forecast period. This is simply attributed to the rising demand for the dental implants to improve physical appearances of face. According to the American Academy of Implant Dentistry (AAID), around 3 million US people have dental implants and it is expected to grow by 500,000 per year. Hence, the rising adoption of dental implants is estimated to drive the market growth in the forthcoming years.

Biomaterial Insights

Based on the biomaterial, the metallic segment dominated the global implantable medical devices market in 2023, in terms of revenue. This can be attributed to the rising cases of road accidents and trauma cases across the globe coupled with the rising demand for the minimally invasive surgeries among the people. Moreover, the dominance of this segment is attributed to the increased adoption of the metal implants in the orthopedic surgeries to provide strong support to the damaged bones or joints. Hence, this segment is further expected to grow owing to the rising cases of arthritis among the global population.

Key Companies & Market Share Insights

The market is moderately fragmented with the presence of several local companies. These market players are striving to gain higher market share by adopting strategies, such as investments, partnerships, and acquisitions & mergers. Companies are also spending on the development of improved products. Moreover, they are also focusing on maintaining competitive pricing.

Key Players includes:

• Abbott Laboratories
• Biotronik SE & Co. KG
• Boston Scientific Corporation
• C. R. Bard, Inc.
• Cardinal Health, Inc.
• CONMED Corporation
• Globus Medical, Inc.
• Integra Lifesciences Holdings Corporation
• Johnson & Johnson
• LivaNova PLC
• Medtronic plc
• NuVasive, Inc.
• Smith & Nephew plc
• St. Jude Medical, Inc.
• InstitutStraumann AG

Segments Covered in the Report

By Product Type

• Cardiovascular Implants
• Orthopedic Implants
• Opthalmology Implants
• Dental Implants
• Cochlear Implants
• Microchip Implants
• Others

By Biomaterial

• Ceramic
• Metallic
• Polymers
• Natural

By End-User

• Hospitals
• Ambulatory Surgical Centers
• Clinics

By Geography

• North America
  • U.S.
  • Canada
• Europe
  • U.K.
  • Germany
  • France
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
• Rest of the World